CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426 | -39.7% | 1,200 | 0.0% | 0.00% | – |
| Q2 2023 | $707 | +3.2% | 1,200 | 0.0% | 0.00% | – |
| Q1 2023 | $685 | -15.2% | 1,200 | -1.0% | 0.00% | – |
| Q4 2022 | $808 | -59.6% | 1,212 | +1.0% | 0.00% | – |
| Q3 2022 | $2,000 | -98.5% | 1,200 | -96.4% | 0.00% | – |
| Q4 2021 | $131,000 | -77.8% | 33,762 | -69.9% | 0.00% | – |
| Q3 2021 | $591,000 | -17.7% | 112,221 | -7.5% | 0.00% | – |
| Q2 2021 | $718,000 | +1.0% | 121,275 | +21.3% | 0.00% | – |
| Q1 2021 | $711,000 | -20.8% | 100,000 | -13.0% | 0.00% | – |
| Q4 2020 | $898,000 | +44800.0% | 115,000 | +28650.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |